Literature DB >> 25224482

Cancer- and treatment-related cognitive changes: what can we do now? What lies ahead?

Catherine M Bender, John D Merriman.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25224482      PMCID： PMC4261918     

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN： 0890-9091            Impact factor:   2.990


× No keyword cloud information.
  32 in total

1.  Cancer as a risk factor for dementia: a house built on shifting sand.

Authors:  Jeffrey S Wefel; Christina A Meyers
Journal:  J Natl Cancer Inst       Date:  2005-06-01       Impact factor: 13.506

2.  Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy.

Authors:  F S van Dam; S B Schagen; M J Muller; W Boogerd; E vd Wall; M E Droogleever Fortuyn; S Rodenhuis
Journal:  J Natl Cancer Inst       Date:  1998-02-04       Impact factor: 13.506

3.  International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer.

Authors:  Jeffrey S Wefel; Janette Vardy; Tim Ahles; Sanne B Schagen
Journal:  Lancet Oncol       Date:  2011-02-25       Impact factor: 41.316

Review 4.  Estrogen and cognitive aging in women.

Authors:  B B Sherwin
Journal:  Neuroscience       Date:  2005-11-28       Impact factor: 3.590

5.  Cognitive-behavioral management of chemotherapy-related cognitive change.

Authors:  Robert J Ferguson; Tim A Ahles; Andrew J Saykin; Brenna C McDonald; Charlotte T Furstenberg; Bernard F Cole; Leila A Mott
Journal:  Psychooncology       Date:  2007-08       Impact factor: 3.894

6.  Pre-treatment factors related to cognitive functioning in women newly diagnosed with breast cancer.

Authors:  Bernadine Cimprich; Heeyoung So; David L Ronis; Christine Trask
Journal:  Psychooncology       Date:  2005-01       Impact factor: 3.894

7.  A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer.

Authors:  Helen G Mar Fan; Mark Clemons; Wei Xu; Irene Chemerynsky; Henriette Breunis; Sharon Braganza; Ian F Tannock
Journal:  Support Care Cancer       Date:  2007-10-31       Impact factor: 3.603

Review 8.  Renaming "chemobrain".

Authors:  Arti Hurria; George Somlo; Tim Ahles
Journal:  Cancer Invest       Date:  2007-09       Impact factor: 2.176

9.  What do perceived cognitive problems reflect?

Authors:  Catherine M Bender; Maria L Pacella; Susan M Sereika; Adam M Brufsky; Victor G Vogel; Priya Rastogi; Frances E Casillo; Susan M Richey; Christopher M Ryan
Journal:  J Support Oncol       Date:  2008 May-Jun

10.  Cognitive function in breast cancer patients prior to adjuvant treatment.

Authors:  Tim A Ahles; Andrew J Saykin; Brenna C McDonald; Charlotte T Furstenberg; Bernard F Cole; Brett S Hanscom; Tamsin J Mulrooney; Gary N Schwartz; Peter A Kaufman
Journal:  Breast Cancer Res Treat       Date:  2007-08-03       Impact factor: 4.872
View more
  3 in total

1.  Protocol for Exercise Program in Cancer and Cognition (EPICC): A randomized controlled trial of the effects of aerobic exercise on cognitive function in postmenopausal women with breast cancer receiving aromatase inhibitor therapy.

Authors:  Amanda L Gentry; Kirk I Erickson; Susan M Sereika; Frances E Casillo; Mary E Crisafio; Patrick T Donahue; George A Grove; Anna L Marsland; Jennifer C Watt; Catherine M Bender
Journal:  Contemp Clin Trials       Date:  2018-03-06       Impact factor: 2.226

2.  Characteristics associated with inter-individual differences in the trajectories of self-reported attentional function in oncology outpatients receiving chemotherapy.

Authors:  Juliet Shih; Heather Leutwyler; Christine Ritchie; Steven M Paul; Jon D Levine; Bruce Cooper; Fay Wright; Yvette P Conley; Christine Miaskowski
Journal:  Support Care Cancer       Date:  2016-10-20       Impact factor: 3.603

3.  Quality of life and psychological functioning in postmenopausal women undergoing aromatase inhibitor treatment for early breast cancer.

Authors:  Gabriella Martino; Antonino Catalano; Rita Maria Agostino; Federica Bellone; Nunziata Morabito; Carmen Giulia Lasco; Carmelo Mario Vicario; Peter Schwarz; Ulla Feldt-Rasmussen
Journal:  PLoS One       Date:  2020-03-26       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.